All Articles

A new affiliate program offers lifetime revenue share, promising a paradigm shift for partners. But can this model sustain itself, or is it a risky gamble?

The construction giant capitalized on a public works boom for record sales, but an equipment failure and soaring expenses reveal deep operational challenges.

An Austrian firm’s AI lets technicians talk to machines, cutting setup from months to weeks. This offline system may solve industrial automation's biggest bottleneck.

A new partnership between Wealth.com and FMG Suite isn't just a tech deal; it's a model for how institutional innovation can finally solve the advisor's dilemma.

DCI Group's hire of CNN veteran Kate Bennett is more than a revolving door move; it's a strategic acquisition of narrative control for the C-suite.

EY Canada moves quantum from lab to ledger with an in-house machine, betting on data sovereignty and practical solutions to solve complex business problems.

LXP Industrial Trust's era as a public REIT ends in a $5.2B acquisition, a deal that signals institutional investors' relentless pursuit of Class A warehouses.

Beyond a dividend king's payout, Stepan's specialty chemicals form the unseen infrastructure of our world, from sustainable cities to global supply chains.

With Q2 earnings soaring and its outlook raised, Bunge is proving its Viterra merger was a strategic masterstroke, creating an agile giant in a volatile world.

Reseda Group's strategic investment in Stickley on Security aims to democratize enterprise-grade cybersecurity for credit unions of all sizes.

While giants may stumble, Mississippi's BankFirst posts stellar growth. We'll unpack how strategic acquisitions and a savvy community lending play are redefining success.

Generac's Q2 results reveal a strategic triumph, with a 29% C&I surge from hyperscale deals offsetting a residential dip. Is this a sustainable power play?

VF Corp raises its outlook on strong North Face and Timberland sales, yet a struggling Vans and an earnings miss send its stock tumbling. Is this a true rebound?

Facing a harsh new Nasdaq rule, HCTI used legacy M&A deals to boost its market value, tying its survival to a strategic pivot toward AI and global expansion.

Beyond record profits, GD's latest report reveals surging demand in private jets and naval power, signaling key shifts in the 2026 global economy.

An FDA panel's nod to controversial peptides seems to validate Hydreight's long-term strategy. But a closer look reveals a long road and a deep data gap.

VanEck's new partnership with tech platform Allocate signals a seismic shift, using an 'operating system' to bring elite private markets to wealth advisors.

A single IV shot to halt Parkinson's? Shape Therapeutics' radical RNA-editing therapy, now backed by The Michael J. Fox Foundation, aims to do just that.

AI now generates exploits in minutes, leaving security teams defenseless. A new technology promises a shield inside the code itself, but can it win the war?